These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 25449433

  • 1. Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells.
    Guerra B, Rasmussen TD, Schnitzler A, Jensen HH, Boldyreff BS, Miyata Y, Marcussen N, Niefind K, Issinger OG.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):751-61. PubMed ID: 25449433
    [Abstract] [Full Text] [Related]

  • 2. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM, Padgaonkar AA, Jalota-Badhwar A, Rao SV, Joshi KS.
    Prostate Cancer Prostatic Dis; 2012 Mar 28; 15(1):15-27. PubMed ID: 22083267
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2.
    Prudent R, Moucadel V, Nguyen CH, Barette C, Schmidt F, Florent JC, Lafanechère L, Sautel CF, Duchemin-Pelletier E, Spreux E, Filhol O, Reiser JB, Cochet C.
    Cancer Res; 2010 Dec 01; 70(23):9865-74. PubMed ID: 21118972
    [Abstract] [Full Text] [Related]

  • 4. Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level.
    Hubert A, Paris S, Piret JP, Ninane N, Raes M, Michiels C.
    J Cell Sci; 2006 Aug 15; 119(Pt 16):3351-62. PubMed ID: 16882692
    [Abstract] [Full Text] [Related]

  • 5. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 6. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S, Brancalion A, Tubi LQ, Colpo A, Pavan L, Cabrelle A, Ave E, Zaffino F, Di Maira G, Ruzzene M, Adami F, Zambello R, Pitari MR, Tassone P, Pinna LA, Gurrieri C, Semenzato G, Piazza F.
    Clin Cancer Res; 2012 Apr 01; 18(7):1888-900. PubMed ID: 22351691
    [Abstract] [Full Text] [Related]

  • 7. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
    Guerra B, Hochscherf J, Jensen NB, Issinger OG.
    Mol Cell Biochem; 2015 Aug 01; 406(1-2):151-61. PubMed ID: 25963666
    [Abstract] [Full Text] [Related]

  • 8. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
    Yao K, Youn H, Gao X, Huang B, Zhou F, Li B, Han H.
    Prostate; 2012 Sep 15; 72(13):1423-30. PubMed ID: 22290244
    [Abstract] [Full Text] [Related]

  • 9. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo.
    Zhao Y, Yu D, Wu H, Liu H, Zhou H, Gu R, Zhang R, Zhang S, Wu G.
    Int J Oncol; 2014 Feb 15; 44(2):451-8. PubMed ID: 24297449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Druggability of the CK2 inhibitor CX-4945 as an anticancer drug and beyond.
    Kim J, Kim SH.
    Arch Pharm Res; 2012 Aug 15; 35(8):1293-6. PubMed ID: 22941473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y.
    Urol Int; 2012 Aug 15; 88(1):95-101. PubMed ID: 22041818
    [Abstract] [Full Text] [Related]

  • 14. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P, Mateo J.
    Oncogene; 2009 Jan 22; 28(3):313-24. PubMed ID: 18978810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC, Lee CF, Huang WH, Chou TC.
    Biochem Pharmacol; 2013 May 01; 85(9):1278-87. PubMed ID: 23416116
    [Abstract] [Full Text] [Related]

  • 17. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro.
    Koronkiewicz M, Chilmonczyk Z, Kazimierczuk Z.
    Anticancer Res; 2013 Nov 01; 33(11):4891-9. PubMed ID: 24222126
    [Abstract] [Full Text] [Related]

  • 18. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
    Schwock J, Geddie WR, Hedley DW.
    Cytometry A; 2005 Dec 01; 68(2):59-70. PubMed ID: 16228978
    [Abstract] [Full Text] [Related]

  • 19. [Casein kinase 2, the versatile regulator of cell survival].
    Volodina IuL, Shtil' AA.
    Mol Biol (Mosk); 2012 Dec 01; 46(3):423-33. PubMed ID: 22888632
    [Abstract] [Full Text] [Related]

  • 20. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
    Chen H, Guan Y, Yuan G, Zhang Q, Jing N.
    Bioorg Med Chem; 2014 Feb 15; 22(4):1496-505. PubMed ID: 24485121
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.